Researchers identify promising new compounds to potentially treat novel coronaviruses
Week Ahead – Focus stays on COVID
Tactical asset allocation — November 2020
Extra Crunch roundup: Inside DoorDash’s IPO, first-person founder stories, the latest in fintech VC and more
Yes, New York Can Limit Gatherings in Private Homes
Activism Is Picking Up But U.S. Still Down 14%
Biden Appears To Back-Pedal On Mask Pledge From A "Mandate" To An "Urging"
In Stark Reversal To Wall Street Bullishness, Bank of America Now Says To "Sell The Vaccine"
World’s top intensive care body advises against remdesivir for sickest Covid patients
How Effective Will Lilly’s Bamlanivimab be in the Battle Against Covid-19?
A CRISPR Approach to Genetic Medicine
How COVID-19 accelerated DoorDash’s business
Euro Rallies on Upbeat Sentiment and Mixed Euro Area Macro Prints
3 "Strong Buy" Dividend Stocks Yielding at Least 10%
NYC Prepares To Close Schools, Puerto Rico Orders National Guard To Help Enforce New COVID-19 Curfew: Live Updates